When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BYSI - FDA on board with endpoint change in study of BeyondSpring's Plinabulin
BeyondSpring Inc.
BeyondSpring (BYSI+4.5%) announces that the FDA has signed off on changing the primary endpoint of its Phase 3 clinical trial, Study 106, evaluating lead drug Plinabulin for the prevention of chemo-induced neutropenia (abnormally low levels of a type of white blood cell called neutrophils).
More news on: BeyondSpring Inc., Amgen Inc., Healthcare stocks news, Stocks on the move,